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Bartonella species are emerging as an important cause of blood culture-negative endo-
carditis, but the optimal management of this disease has not been fully deﬁned. We
describe a case of subacute Bartonella henselae endocarditis of a prosthetic aortic valve in
an immunocompetent woman that was cured with long-term antibiotic therapy alone. In
addition, we demonstrate that follow-up of serologic titers against B. henselaewas helpful
in assessing deﬁnitive cure of the infection.
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Bartonella species are emerging as an important
cause of blood culture-negative endocarditis [1].
The optimal management of this disease has not
been fully deﬁned, and many patients will require
both antibiotic therapy and surgical valve replace-
ment. In addition, the value of serologic follow-up
to assess deﬁnitive cure of the infection has not
been demonstrated. We report herein a case of
Bartonella henselae endocarditis of a prosthetic aor-
tic valve that was cured with long-term antibiotic
therapy alone. Follow-up of serologic titers
appeared helpful in assessing the cure.
A 70-year-old-immunocompetent woman was
admitted following a 5-month history of fever and
chills. Her medical history included aortic valve
replacement by a bioprosthesis 3 years previously
for degenerative valvular disease. She owned a cat
but did not recall it scratching her before the onset
of symptoms. On admission, her temperature was
39 8C, and examination revealed a left facial palsy,
purpura of the toes, and a grade 4/6 systolic
murmur of the bioprosthesis. Laboratory results
included an erythrocyte sedimentation rate of
68mm/h, and a positive rheumatoid factor
(30 IU/mL). Transesophageal echocardiography
revealed nodular thickening and oscillating echoes
of the anterior cusp of the aortic valve. A brain CT
scan revealed recent infarction in the left parietal
region. All blood culture specimens, which were
incubated for up to 21 days, remained negative.
However, an indirect ﬂuorescent antibody test
(MRL Diagnostics, Cypress, CA, USA) revealed
markedly elevated antibody titers to B. henselae
(1 : 8192). For this test, antibody titers >1 : 256
are considered evidence of recent infection. A
serum sample was sent to the reference center
for the diagnosis of rickettsioses (Unite´ des Rick-
ettsies, Marseille, France). B. quintana, Oklahoma
strain, B. henselae, Houston-1 strain and B. henselae,
serotype Marseille were used as antigens in a
microimmunoﬂuorescence assay, as reported else-
where [2]. With this assay, the patient’s serumwas
positive at a titer of 1 : 12 800 when B. henselae,
serotype Marseille, was used as the antigen.
Low titers to B. henselae Houston-1 strain (1 : 800)
and B. quintana (1 : 100) were found. No serologic
evidence of infection with Brucella, Chlamydia,
Coxiella burnetii, Mycoplasma or Legionella species
was found.
Subacute endocarditis due to B. henselae was
diagnosed, and antibiotic therapy with intrave-
nous amoxicillin, gentamicin and doxycycline
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was initiated. The patient’s fever gradually disap-
peared within 4weeks. At that time, antibiotic
therapy was switched to oral doxycycline and
intravenous ceftriaxone. Four weeks later, the
patient was afebrile and asymptomatic. Ceftriax-
one was stopped and the patient received long-
term oral doxycycline for 30months with serial
serologic testing. For this purpose, sera were
stored and then run simultaneously. At the end
of therapy, titers of antibody to B. henselae were
low and stable (Table 1). Transthoracic echocar-
diography showed no changing lesion, and the
bioprosthesis function was satisfactory. Follow-up
examinations over 10months following the com-
pletion of therapy disclosed no evidence of recur-
rent endocarditis.
According to the Duke criteria, a deﬁnite diag-
nosis of infective endocarditis was made, based
on the combination of ﬁve minor criteria, i.e. pre-
disposing heart condition, fever, vascular and
immunologic phenomena, and transesophageal
echocardiography ﬁndings [3]. Bartonella endo-
carditis was suspected because the patient owned
a cat and all blood cultures remained negative.
This diagnosis was supported by the markedly
elevated serum levels of antibodies to B. henselae
found before administration of antibiotics. It
has been suggested that a positive result of a
serologic test for Bartonella species may be added
as a minor criterion for the diagnosis of endo-
carditis [1,4].
The optimal choice and duration of antibiotic
therapy for bartonella endocarditis are unknown
[1]. Although Bartonella species are highly suscep-
tible in vitro tomany antibiotics, such as b-lactams,
aminoglycosides, erythromycin or doxycycline,
treatment failures and relapses are common, espe-
cially following brief antibiotic courses [5]. Bacter-
icidal studies in a cellular model have suggested
that this discrepancy may be due to a lack of
bactericidal effect of antibiotics on Bartonella;
among various antibiotics tested in this model,
only aminoglycosides were bactericidal [6]. Our
patient was successfully treated with a combina-
tion of a b-lactam, gentamicin, and doxycycline.
The clinical features in this case contrasted with
the usually aggressive course of bartonella endo-
carditis previously reported. Isolated case reports
and an analysis of a series of 22 patients suggest
that bartonella endocarditis is associated with a
high frequency of vegetation (86%) and embolic
phenomena (41%) [1,7,8]. In the largest series
reported, 95.8% of patients underwent surgery
because of severe valvular damage at the time
of diagnosis [9]. To our knowledge, cure of sub-
acute bartonella endocarditis of a bioprosthetic
valve with antibiotics alone has never been
reported.
Since no criteria for cure have been proposed at
this time, the optimal duration of antibiotic treat-
ment is difﬁcult to deﬁne. Experience with Q fever
endocarditis has suggested that deﬁnite cure is
indicated by low titers of phase I IgA and IgG
(¼ 1 : 200) [10].Markedly elevated titers of IgG to B.
henselae have been recorded in an immunocompe-
tent man 18months after valve replacement and
prolonged antibiotic therapy [7]. In our patient,
IgG titers only decreased after 12months of ther-
apy, and remained low and stable even after dis-
continuation of therapy, suggesting that there
were no residual infectious organisms within the
prosthetic valve at that time.We suggest that serial
serologic testing may help the clinician to deﬁne
the appropriate duration of antibiotic therapy for
bartonella endocarditis.
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